189 related articles for article (PubMed ID: 28527270)
1. [Effect of antenatal spiramycin treatment on the frequency of retinochoroiditis due to congenital toxoplasmosis in a Colombian cohort].
Zuluaga LM; Hernández JC; Castaño CF; Donado JH
Biomedica; 2017 Apr; 37(0):86-91. PubMed ID: 28527270
[TBL] [Abstract][Full Text] [Related]
2. Assessment of laboratory methods used in the diagnosis of congenital toxoplasmosis after maternal treatment with spiramycin in pregnancy.
Rodrigues IM; Costa TL; Avelar JB; Amaral WN; Castro AM; Avelino MM
BMC Infect Dis; 2014 Jun; 14():349. PubMed ID: 24961630
[TBL] [Abstract][Full Text] [Related]
3. [Prevention of congenital toxoplasmosis].
Russo M; Galanti B
Clin Ter; 1990 Sep; 134(6):383-92. PubMed ID: 2149535
[TBL] [Abstract][Full Text] [Related]
4. Congenital toxoplasmosis and prenatal care state programs.
Avelino MM; Amaral WN; Rodrigues IM; Rassi AR; Gomes MB; Costa TL; Castro AM
BMC Infect Dis; 2014 Jan; 14():33. PubMed ID: 24438336
[TBL] [Abstract][Full Text] [Related]
5. Congenital Toxoplasmosis and Long-term Outcomes.
Gundeslioglu OO; Haytoglu Z; Esen E; Alabaz D; Cay U; Ozlu F; Kibar F; Cetiner S
Turkiye Parazitol Derg; 2024 Mar; 48(1):8-14. PubMed ID: 38449361
[TBL] [Abstract][Full Text] [Related]
6. Effect of prenatal treatment on the risk of intracranial and ocular lesions in children with congenital toxoplasmosis.
Gras L; Gilbert RE; Ades AE; Dunn DT
Int J Epidemiol; 2001 Dec; 30(6):1309-13. PubMed ID: 11821335
[TBL] [Abstract][Full Text] [Related]
7. [Diagnosis and therapy of congenital toxoplasmosis].
Friese K; Weigel M; Melchert F
Dtsch Med Wochenschr; 1993 Dec; 118(49):1814-6. PubMed ID: 8253045
[No Abstract] [Full Text] [Related]
8. Predictors of retinochoroiditis in children with congenital toxoplasmosis: European, prospective cohort study.
Freeman K; Tan HK; Prusa A; Petersen E; Buffolano W; Malm G; Cortina-Borja M; Gilbert R;
Pediatrics; 2008 May; 121(5):e1215-22. PubMed ID: 18426852
[TBL] [Abstract][Full Text] [Related]
9. Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centres.
Gras L; Wallon M; Pollak A; Cortina-Borja M; Evengard B; Hayde M; Petersen E; Gilbert R;
Acta Paediatr; 2005 Dec; 94(12):1721-31. PubMed ID: 16421031
[TBL] [Abstract][Full Text] [Related]
10. Prophylaxis of congenital toxoplasmosis. Effects of spiramycin on placental infection.
Couvreur J; Desmonts G; Thulliez P
J Antimicrob Chemother; 1988 Jul; 22 Suppl B():193-200. PubMed ID: 3182443
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data.
; Thiébaut R; Leproust S; Chêne G; Gilbert R
Lancet; 2007 Jan; 369(9556):115-22. PubMed ID: 17223474
[TBL] [Abstract][Full Text] [Related]
12. [Strategies for the diagnosis and treatment of prenatal toxoplasmosis - a survey].
Christoph J; Kattner E; Seitz HM; Reiter-Owona I
Z Geburtshilfe Neonatol; 2004 Feb; 208(1):10-6. PubMed ID: 15039886
[TBL] [Abstract][Full Text] [Related]
13. Outcome of toxoplasmosis acquired during pregnancy following treatment in both pregnancy and early infancy.
Galanakis E; Manoura A; Antoniou M; Sifakis S; Korakaki E; Hatzidaki E; Lambraki D; Tselentis Y; Giannakopoulou C
Fetal Diagn Ther; 2007; 22(6):444-8. PubMed ID: 17652934
[TBL] [Abstract][Full Text] [Related]
14. [Diagnosis and treatment of congenital toxoplasmosis].
Koskiniemi M
Duodecim; 1993; 109(14):1260-4. PubMed ID: 8062703
[No Abstract] [Full Text] [Related]
15. Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment.
Hohlfeld P; Daffos F; Thulliez P; Aufrant C; Couvreur J; MacAleese J; Descombey D; Forestier F
J Pediatr; 1989 Nov; 115(5 Pt 1):765-9. PubMed ID: 2681638
[TBL] [Abstract][Full Text] [Related]
16. [Congenital toxoplasmosis retinochoroiditis after primary infection of the mother in pregnancy].
Kuchar A; Hayde M; Steinkogler FJ
Ophthalmologe; 1996 Apr; 93(2):190-3. PubMed ID: 8652987
[TBL] [Abstract][Full Text] [Related]
17. [Diagnosis and therapy of toxoplasmosis infections in pregnancy at the Rostock University Gynecologic Clinic 1986-1994].
Briese V; Rogmann K; Müller H; Plesse R
Zentralbl Gynakol; 1995; 117(11):578-84. PubMed ID: 8533491
[TBL] [Abstract][Full Text] [Related]
18. The ocular manifestations of congenital infection: a study of the early effect and long-term outcome of maternally transmitted rubella and toxoplasmosis.
O'Neill JF
Trans Am Ophthalmol Soc; 1998; 96():813-79. PubMed ID: 10360309
[TBL] [Abstract][Full Text] [Related]
19. [Toxoplasmosis in pregnancy. Diagnosis and new therapeutic possibilities].
Mirlesse V; Jacquemard F; Daffos F
Presse Med; 1993 Feb; 22(6):258-62. PubMed ID: 8511144
[TBL] [Abstract][Full Text] [Related]
20. Treatment of toxoplasmosis in the pregnant mother and newborn child.
Stray-Pedersen B
Scand J Infect Dis Suppl; 1992; 84():23-31. PubMed ID: 1290070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
